1
|
Yokota J, Shiraishi K and Kohno T: Genetic
basis for susceptibility to lung cancer: Recent progress and future
directions. Adv Cancer Res. 109:51–72. 2010.PubMed/NCBI View Article : Google Scholar
|
2
|
Dela Cruz CS, Tanoue LT and Matthay RA:
Lung cancer: Epidemiology, etiology, and prevention. Clin Chest
Med. 32:605–644. 2011.PubMed/NCBI View Article : Google Scholar
|
3
|
Pesch B, Kendzia B, Gustavsson P, Jöckel
KH, Johnen G, Pohlabeln H, Olsson A, Ahrens W, Gross IM, Brüske I,
et al: Cigarette smoking and lung cancer-relative risk estimates
for the major histological types from a pooled analysis of
case-control studies. Int J Cancer. 131:1210–1219. 2012.PubMed/NCBI View Article : Google Scholar
|
4
|
Carmines EL: Evaluation of the potential
effects of ingredients added to cigarettes. Part 1: Cigarette
design, testing approach, and review of results. Food Chem Toxicol.
40:77–91. 2002.PubMed/NCBI View Article : Google Scholar
|
5
|
Baker RR, Pereira da Silva JR and Smith G:
The effect of tobacco ingredients on smoke chemistry. Part I:
Flavourings and additives. Food Chem Toxicol. 42 (Suppl):S3–S37.
2004.PubMed/NCBI View Article : Google Scholar
|
6
|
Greenbaum L and Lerer B: Differential
contribution of genetic variation in multiple brain nicotinic
cholinergic receptors to nicotine dependence: Recent progress and
emerging open questions. Mol Psychiatry. 14:912–945.
2009.PubMed/NCBI View Article : Google Scholar
|
7
|
Lassi G, Taylor AE, Timpson NJ, Kenny PJ,
Mather RJ, Eisen T and Munafò MR: The CHRNA5-A3-B4 gene cluster and
smoking: From discovery to therapeutics. Trends Neurosci.
39:851–861. 2016.PubMed/NCBI View Article : Google Scholar
|
8
|
Dani JA and Harris RA: Nicotine addiction
and comorbidity with alcohol abuse and mental illness. Nat
Neurosci. 8:1465–1470. 2005.PubMed/NCBI View
Article : Google Scholar
|
9
|
Drew AE, Derbez AE and Werling LL:
Nicotinic receptor-mediated regulation of dopamine transporter
activity in rat prefrontal cortex. Synapse. 38:10–16.
2000.PubMed/NCBI View Article : Google Scholar
|
10
|
Fowler JS, Logan J, Wang GJ and Volkow ND:
Monoamine oxidase and cigarette smoking. Neurotoxicology. 24:75–82.
2003.PubMed/NCBI View Article : Google Scholar
|
11
|
Sagud M, Mihaljević-Peles A, Mück-Seler D,
Pivac N, Vuksan-Cusa B, Brataljenović T and Jakovljević M: Smoking
and schizophrenia. Psychiatr Danub. 21:371–375. 2009.PubMed/NCBI
|
12
|
D'Souza MS and Markou A: Neuronal
mechanisms underlying development of nicotine dependence:
Implications for novel smoking-cessation treatments. Addict Sci
Clin Pract. 6:4–16. 2011.PubMed/NCBI
|
13
|
Hecht SS: Tobacco carcinogens, their
biomarkers and tobacco-induced cancer. Nat Rev Cancer. 3:733–744.
2003.PubMed/NCBI View
Article : Google Scholar
|
14
|
Bierut LJ, Madden PA, Breslau N, Johnson
EO, Hatsukami D, Pomerleau OF, Swan GE, Rutter J, Bertelsen S, Fox
L, et al: Novel genes identified in a high-density genome wide
association study for nicotine dependence. Hum Mol Genet. 16:24–35.
2007.PubMed/NCBI View Article : Google Scholar
|
15
|
Saccone SF, Hinrichs AL, Saccone NL, Chase
GA, Konvicka K, Madden PA, Breslau N, Johnson EO, Hatsukami D,
Pomerleau O, et al: Cholinergic nicotinic receptor genes implicated
in a nicotine dependence association study targeting 348 candidate
genes with 3713 SNPs. Hum Mol Genet. 16:36–49. 2007.PubMed/NCBI View Article : Google Scholar
|
16
|
Amos CI, Wu X, Broderick P, Gorlov IP, Gu
J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, et al:
Genome-wide association scan of tag SNPs identifies a
susceptibility locus for lung cancer at 15q25.1. Nat Genet.
40:616–622. 2008.PubMed/NCBI View
Article : Google Scholar
|
17
|
Wosik K, Cayrol R, Dodelet-Devillers A,
Berthelet F, Bernard M, Moumdjian R, Bouthillier A, Reudelhuber TL
and Prat A: Angiotensin II controls occludin function and is
required for blood brain barrier maintenance: Relevance to multiple
sclerosis. J Neurosci. 27:9032–9042. 2007.PubMed/NCBI View Article : Google Scholar
|
18
|
Nawaz SK and Hasnain S: Pleiotropic
effects of ACE polymorphism. Biochem Med. 19:36–49. 2008.
|
19
|
van der Knaap R, Siemes C, Coebergh JW,
van Duijn CM, Hofman A and Stricker BH: Renin-angiotensin system
inhibitors, angiotensin I-converting enzyme gene insertion/deletion
polymorphism, and cancer: The rotterdam study. Cancer. 112:748–757.
2008.PubMed/NCBI View Article : Google Scholar
|
20
|
van Haaster MC, McDonough AA and Gurley
SB: Blood pressure regulation by the angiotensin type 1 receptor in
the proximal tubule. Curr Opin Nephrol Hypertens. 27:1–7.
2018.PubMed/NCBI View Article : Google Scholar
|
21
|
Jenkins TA, Allen AM, Chai SY, MacGregor
DP, Paxinos G and Mendelsohn FA: Interactions of angiotensin II
with central dopamine. Adv Exp Med Biol. 396:93–103.
1996.PubMed/NCBI View Article : Google Scholar
|
22
|
Jenkins TA, Mendelsohn FA and Chai SY:
Angiotensin-converting enzyme modulates dopamine turnover in the
striatum. J Neurochem. 68:1304–1311. 1997.PubMed/NCBI View Article : Google Scholar
|
23
|
Obata T, Takahashi S, Kashiwagi Y and
Kubota S: Protective effect of captopril and enalaprilat,
angiotensin-converting enzyme inhibitors, on
para-nonylphenol-induced *OH generation and dopamine efflux in rat
striatum. Toxicology. 250:96–99. 2008.PubMed/NCBI View Article : Google Scholar
|
24
|
Rigat B, Hubert C, Alhenc-Gelas F, Cambien
F, Corvol P and Soubrier F: An insertion/deletion polymorphism in
the angiotensin I-converting enzyme gene accounting for half the
variance of serum enzyme levels. J Clin Invest. 86:1343–1346.
1990.PubMed/NCBI View Article : Google Scholar
|
25
|
Hubacek JA, Pitha J, Skodova Z and Poledne
R: Angiotensin converting enzyme gene-a candidate gene for
addiction to smoking? Atherosclerosis. 159:237–238. 2001.PubMed/NCBI View Article : Google Scholar
|
26
|
Hubacek JA, Adamkova V, Skodova Z, Lanska
V and Poledne R: No relation between angiotensin-converting enzyme
gene polymorphism and smoking dependence. Scand J Clin Lab Invest.
64:575–578. 2004.PubMed/NCBI View Article : Google Scholar
|
27
|
Baghai TC, Varallo-Bedarida G, Born C,
Häfner S, Schule C, Eser D, von Schacky C, Rupprecht R and Bondy B:
A polymorphism in the angiotensin-converting enzyme gene is
associated with smoking behavior. J Clin Psychiatry. 69:1983–1985.
2008.PubMed/NCBI View Article : Google Scholar
|
28
|
Nadalin S, Buretić-Tomljanović A, Lavtar
P, Starčević Čizmarević N, Hodžić A, Sepčić J, Kapović M, Peterlin
B and Ristić S: The lack of association between
angiotensin-converting enzyme gene insertion/deletion polymorphism
and nicotine dependence in multiple sclerosis. Brain Behav.
7(e00600)2016.PubMed/NCBI View
Article : Google Scholar
|
29
|
Nadalin S, Ristić S, Rebić J, Šendula
Jengić V, Kapović M and Buretić-Tomljanović A: The
insertion/deletion polymorphism in the angiotensin-converting
enzyme gene and nicotine dependence in schizophrenia patients. J
Neural Transm (Vienna). 124:511–518. 2017.PubMed/NCBI View Article : Google Scholar
|
30
|
Cheon KT, Choi KH, Lee HB, Park SK, Rhee
YK and Lee YC: Gene polymorphisms of endothelial nitric oxide
synthase and angiotensin-converting enzyme in patients with lung
cancer. Lung. 178:351–360. 2000.PubMed/NCBI View Article : Google Scholar
|
31
|
Wang HW, Nie ZS, Duan YZ, Liu DD, Han ZH,
Zhang XH and Hua B: Association between polymorphism in ACE gene
with lung cancer and COPD patients. Bei Jing Yi Xue. 22:364–365.
2000.(In Chinese).
|
32
|
Zhang Q, Liu X, Zhang Z and Wang L:
Analysis of the relationship between polymorphism of
angiotensin-converting enzyme gene and lung cancer. Zhongguo Fei Ai
Za Zhi. 8:211–214. 2005.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
33
|
Yaren A, Oztop I, Turgut S, Turgut G,
Degirmencioglu S and Demirpence M: Angiotensin-converting enzyme
gene polymorphism is associated with anemia in non small-cell lung
cancer. Exp Biol Med (Maywood). 233:32–37. 2008.PubMed/NCBI View Article : Google Scholar
|
34
|
Nacak M, Nacak I, Sanli M, Ozkur M, Pektaş
M and Aynacioğlu AS: Association of angiotensin converting enzyme
gene insertion/deletion polymorphism with lung cancer in Turkey.
Cancer Genet Cytogenet. 198:22–26. 2010.PubMed/NCBI View Article : Google Scholar
|
35
|
Dević Pavlić S, Ristić S, Flego V, Kapović
M and Radojčić Badovinac A: Angiotensin-converting enzyme
insertion/deletion gene polymorphism in lung cancer patients. Genet
Test Mol Biomarkers. 16:722–725. 2012.PubMed/NCBI View Article : Google Scholar
|
36
|
Peddireddy V, Badabagni SP, Gundimeda SD
and Mundluru HP: Association of eNOS and ACE gene polymorphisms and
plasma nitric oxide with risk of non-small cell lung cancer in
South India. Clin Respir J. 12:207–217. 2018.PubMed/NCBI View Article : Google Scholar
|
37
|
Gao M, Wang Y, Shi Y, Liu D, Liang Y, Yu
Y, Zhaobin J, Zhu L and Jin S: The relationship between three
well-characterized polymorphisms of the angiotensin converting
enzyme gene and lung cancer risk: A case-control study and a
meta-analysis. J Renin Angiotensin Aldosterone Syst. 13:455–460.
2012.PubMed/NCBI View Article : Google Scholar
|
38
|
Cheng Z, Ma R, Tan W, Zhang L and Tan Q:
Lack of association between ACE insertion/deletion polymorphism and
lung cancer: A meta-analysis. J Renin Angiotensin Aldosterone Syst.
16:453–458. 2015.PubMed/NCBI View Article : Google Scholar
|
39
|
Wang N, Yang D, Ji B and Li J:
Angiotensin-converting enzyme insertion/deletion gene polymorphism
and lung cancer risk: A meta-analysis. J Renin Angiotensin
Aldosterone Syst. 16:189–194. 2015.PubMed/NCBI View Article : Google Scholar
|
40
|
Satoh H, Yamashita YT, Ishikawa H, Kamma
H, Ohtsuka M and Sekizawa K: Smoking and smoking-related lung
cancer in female patients. Anticancer Res. 19:5627–5630.
1999.PubMed/NCBI
|
41
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E,
Flieder DB, et al: The 2015 world health organization
classification of lung tumors: Impact of genetic, clinical and
radiologic advances since the 2004 classification. J Thorac Oncol.
10:1243–1260. 2015.PubMed/NCBI View Article : Google Scholar
|
42
|
Detterbeck FC, Boffa DJ, Kim AW and Tanoue
LT: The eighth edition lung cancer stage classification. Chest.
151:193–203. 2017.PubMed/NCBI View Article : Google Scholar
|
43
|
de Leon J and Diaz FJ: A meta-analysis of
worldwide studies demonstrates an association between schizophrenia
and tobacco smoking behaviors. Schizophr Res. 76:135–157.
2005.PubMed/NCBI View Article : Google Scholar
|
44
|
Guo S, Chen DF, Zhou DF, Sun HQ, Wu GY,
Haile CN, Kosten TA, Kosten TR and Zhang XY: Association of
functional catechol O-methyl transferase (COMT) Val108Met
polymorphism with smoking severity and age of smoking initiation in
Chinese male smokers. Psychopharmacology (Berl). 190:449–456.
2007.PubMed/NCBI View Article : Google Scholar
|
45
|
Carlson RV, Boyd KM and Webb DJ: The
revision of the declaration of Helsinki: Past, present and future.
Br J Clin Pharmacol. 57:695–713. 2004.PubMed/NCBI View Article : Google Scholar
|
46
|
Qiagen: FlexiGene DNA Handbook. urihttps://www.qiagen.com/us/resources/resourcedetail?id=6b147421-7846-411e-9993-bb01563b807e&lang=ensimplehttps://www.qiagen.com/us/resources/resourcedetail?id=6b147421-7846-411e-9993-bb01563b807e&lang=en.
Accessed March 6, 2020.
|
47
|
Shanmugam V, Sell KW and Saha BK:
Mistyping ACE heterozygotes. PCR Methods Appl. 3:120–121.
1993.PubMed/NCBI View Article : Google Scholar
|
48
|
Lovrecić L, Ristić S, Starcević-Cizmarević
N, Jazbec SS, Sepcić J, Kapović M and Peterlin B:
Angiotensin-converting enzyme I/D gene polymorphism and risk of
multiple sclerosis. Acta Neurol Scand. 114:374–377. 2006.PubMed/NCBI View Article : Google Scholar
|
49
|
Sipahi T, Budak M, Şen S, Ay A and Şener
S: Association between ACE gene insertion (I)/deletion (D)
polymorphism and primary hypertension in Turkish patients of Trakya
region. Biotechnol Biotechnol Equip. 20:104–108. 2006.
|
50
|
Nadalin S, Buretić-Tomljanović A, Rubeša
G, Jonovska S, Tomljanović D and Ristić S: Angiotensin-converting
enzyme gene insertion/deletion polymorphism is not associated with
schizophrenia in a Croatian population. Psychiatr Genet.
22:267–268. 2012.PubMed/NCBI View Article : Google Scholar
|
51
|
Avila-Vanzzini N, Posadas-Romero C,
Gonzalez-Salazar Mdel C, Maass-Iturbide C, Melendez-Ramirez G,
Perez-Mendez O, Del Valle-Mondragon L, Masso-Rojas F, Varela Lopez
E, Herrera-Bello H, et al: The ACE I/D polymorphism is associated
with nitric oxide metabolite and blood pressure levels in healthy
Mexican men. Arch Cardiol Mex. 85:105–110. 2015.PubMed/NCBI View Article : Google Scholar
|
52
|
Nadalin S, Buretić-Tomljanović A, Ristić
S, Jonovska S and Tomljanović D: The impact of ACE gene I/D
polymorphism on plasma glucose and lipid concentrations in
schizophrenia patients. Psychiatry Res. 227:71–72. 2015.PubMed/NCBI View Article : Google Scholar
|
53
|
Röcken C, Neumann K, Carl-McGrath S, Lage
H, Ebert MP, Dierkes J, Jacobi CA, Kalmuk S, Neuhaus P and Neumann
U: The gene polymorphism of the angiotensin I-converting enzyme
correlates with tumor size and patient survival in colorectal
cancer patients. Neoplasia. 9:716–722. 2007.PubMed/NCBI View Article : Google Scholar
|
54
|
Turek S, Rudan I, Smolej-Narancić N,
Szirovicza L, Cubrilo-Turek M, Zerjavić-Hrabak V, Rak-Kaić A,
Vrhovski-Hebrang D, Prebeg Z, Ljubicić M, et al: A large
cross-sectional study of health attitudes, knowledge, behaviour and
risks in the post-war Croatian population (the first Croatian
health project). Coll Antropol. 25:77–96. 2001.PubMed/NCBI
|
55
|
National Center for Biotechnology
Information, U.S. National Library of Medicine: rs1799752 [Homo
sapiens]. urihttps://www.ncbi.nlm.nih.gov/snp/?term=rs1799752simplehttps://www.ncbi.nlm.nih.gov/snp/?term=rs1799752.
Accessed March 6, 2020.
|
56
|
Li MD: Identifying susceptibility loci for
nicotine dependence: 2008 update based on recent genome-wide
linkage analyses. Hum Genet. 123:119–131. 2008.PubMed/NCBI View Article : Google Scholar
|
57
|
Bierut LJ: Convergence of genetic findings
for nicotine dependence and smoking related diseases with
chromosome 15q24-25. Trends Pharmacol Sci. 31:46–51.
2010.PubMed/NCBI View Article : Google Scholar
|
58
|
Gallagher PE, Li P, Lenhart JR, Chappell
MC and Brosnihan KB: Estrogen regulation of angiotensin-converting
enzyme mRNA. Hypertension. 33:323–328. 1999.PubMed/NCBI View Article : Google Scholar
|
59
|
Sanada M, Higashi Y, Nakagawa K, Sasaki S,
Kodama I, Tsuda M, Nagai N and Ohama K: Relationship between the
angiotensin-converting enzyme genotype and the forearm vasodilator
response to estrogen replacement therapy in postmenopausal women. J
Am Coll Cardiol. 37:1529–1535. 2001.PubMed/NCBI View Article : Google Scholar
|
60
|
Sumino H, Ichikawa S, Ohyama Y, Nakamura
T, Kanda T, Sakamoto H, Sakamaki T, Mizunuma H and Kurabayashi M:
Effects of hormone replacement therapy on serum
angiotensin-converting enzyme activity and plasma bradykinin in
postmenopausal women according to angiotensin-converting
enzyme-genotype. Hypertens Res. 26:53–58. 2003.PubMed/NCBI View Article : Google Scholar
|
61
|
Chavez C, Hollaus M, Scarr E, Pavey G,
Gogos A and van den Buuse M: The effect of estrogen on dopamine and
serotonin receptor and transporter levels in the brain: An
autoradiography study. Brain Res. 1321:51–59. 2010.PubMed/NCBI View Article : Google Scholar
|
62
|
Cosgrove KP, Wang S, Kim SJ, McGovern E,
Nabulsi N, Gao H, Labaree D, Tagare HD, Sullivan JM and Morris ED:
Sex differences in the brain's dopamine signature of cigarette
smoking. J Neurosci. 34:16851–16855. 2014.PubMed/NCBI View Article : Google Scholar
|
63
|
Alifano M, Souazé F, Dupouy S,
Camilleri-Broët S, Younes M, Ahmed-Zaïd SM, Takahashi T,
Cancellieri A, Damiani S, Boaron M, et al: Neurotensin receptor 1
determines the outcome of non-small cell lung cancer. Clin Cancer
Res. 16:4401–4410. 2010.PubMed/NCBI View Article : Google Scholar
|
64
|
Muñoz M, González-Ortega A, Rosso M,
Robles-Frias MJ, Carranza A, Salinas-Martín MV and Coveñas R: The
substance P/neurokinin-1 receptor system in lung cancer: Focus on
the antitumor action of neurokinin-1 receptor antagonists.
Peptides. 38:318–325. 2012.PubMed/NCBI View Article : Google Scholar
|
65
|
Ljungberg L, Alehagen U, Länne T, Björck
H, De Basso R, Dahlström U and Persson K: The association between
circulating angiotensin-converting enzyme and cardiovascular risk
in the elderly: A cross-sectional study. J Renin Angiotensin
Aldosterone Syst. 12:281–289. 2011.PubMed/NCBI View Article : Google Scholar
|
66
|
Laustiola KE, Lassila R and Nurmi AK:
Enhanced activation of the renin-angiotensin-aldosterone system in
chronic cigarette smokers: A study of monozygotic twin pairs
discordant for smoking. Clin Pharmacol Ther. 44:426–430.
1988.PubMed/NCBI View Article : Google Scholar
|